Cure My Disease

Don't miss your cure!

 Log in / Sign up

Heart attack recovery: could Lower-Dose statins be just as good?

NCT ID NCT06782243

Completed Disease control Sponsor: Khyber Medical University Peshawar Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study looked at whether moderate-dose statins work as well as high-dose statins in lowering 'bad' LDL cholesterol after a heart attack. 190 adults aged 25-85 took either a moderate or high dose of atorvastatin or rosuvastatin daily for 3 months. The goal was to see if both groups could achieve a 50% or greater drop in LDL cholesterol, while also tracking side effects like muscle pain and liver issues.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
statins (atorvastatin and rosuvastatin)
What this could lead to
If moderate-intensity statins work as well as high-intensity ones, doctors may prescribe lower doses to reduce side effects and costs for heart attack patients.
What could go wrong
This is a small, completed trial with only 190 participants. The results may not apply to all patients, and moderate doses might not lower cholesterol enough for some high-risk individuals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute coronary syndrome cardiovascular disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE CORONARY SYNDROME

Contacts and locations

Locations

  • MTI-KTH (Medical Teaching Institution-Khyber Teaching Hospital), Peshawar-Pakistan

    Peshawar, Khyber Pakhtunkhwa, 25000, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.